MannKind develops dry powder inhaler for pulmonary hypertension treatment
Go back to MannKind develops dry powder inhaler for pulmonary hypertension treatment| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.11 +0.22 (5.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.89 | 52 Week High | $2.51 | |||
| Open | $3.91 | 52 Week Low | $0.41 | |||
| Day High | $4.15 | P/E | N/A | |||
| Day Low | $3.85 | EPS | $-0.64 | |||
| Volume | 5,047,822 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 538.84 +5.90 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $532.94 | 52 Week High | $164.04 | |||
| Open | $534.84 | 52 Week Low | $97.52 | |||
| Day High | $541.03 | P/E | 98.51 | |||
| Day Low | $524.58 | EPS | $5.47 | |||
| Volume | 1,198,818 | |||||

